News

27

Jun, 2022

EMA updates guideline on the treatment of bacterial infections

Tags: ,

The European Medicines Agency (EMA) has published the final revised guideline on the evaluation of human medicines for the treatment of bacterial infections. The revised guideline reflects the outcome of recent discussions between regulators in the EU, United States and Japan on the development of new antimicrobial medicines. Among others, it includes recommendations on the clinical criteria for patient enrolment, the primary endpoint and the primary analysis in infection site-specific trials. Antimicrobial resistance (AMR) is a global threat that puts children’s health at great risk. WHO estimates that infections caused by multi-drug […]

READ MORE

10

Nov, 2020

Louise Hill Presents NeoVanc Sub-study Results at ESPID 2020

Tags: ,

Louise Hill presented the findings of a NeoVanc sub-study at ESPID’s 2020 Virtual Meeting in late October. Below is a summary of the study and findings. Enterococcus (a bacterium) and candida (a fungus) can sometimes be found on or in the human body.  Occasionally enterococci can develop resistance to one of the antibiotics usually used to treat it – vancomycin. Vancomycin use has been linked to a rise in vancomycin-resistant enterococci and candida on or in the bodies of babies admitted to the neonatal intensive care unit. Babies with vancomycin-resistant […]

READ MORE

2

Jul, 2020

Global sales of oral antibiotics formulated for children

Tags: ,

Authors: Li G, Jackson C, Bielicki J, Ellis S, Hsiac Y, Sharland M Published in: Bulletin of the World Health Organization, July 2020 Objective To investigate international consumption patterns of child-appropriate oral formulations of antibiotics by formulation type, with a focus on dispersible tablets, using data from a global sales database. Methods Antibiotic sales data for 2015 covering 74 countries and regional country groups were obtained from the MIDAS® pharmaceutical sales database, which includes samples of pharmacy wholesalers and retailers. The focus was on sales of child-appropriate oral formulations of […]

READ MORE

28

Apr, 2020

A comparison of five paediatric dosing guidelines for antibiotics

Tags:

Authors: Mathur S, Jackson C, Urus H, Ziarko I, Goodbun M, Hsia Y, Ellis S, Sharland M. Published in: Bulletin of the World Health Organization, April 2020 Objective To compare dosing guidance in the paediatric formularies of high-income countries and emerging economies for 32 commonly prescribed antibiotics on the World Health Organization’s (WHO’s) 2017 Model List of Essential Medicines for Children. Methods We identified paediatric antibiotic guidelines that were either widely used internationally or originated in countries in which antibiotic use has increased markedly in recent years (i.e. Brazil, China, […]

READ MORE
NEWSLETTER

We would like to update you on our recent activities

Subscribe

No thanks, I’m not interested!